Mode
Text Size
Log in / Sign up

Systolic BP 120-140 mm Hg after thrombectomy linked to better stroke outcomesAfter Stroke Surgery, This Blood Pressure Range Leads to Better Recovery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that a systolic BP of 120-140 mm Hg after thrombectomy may be associated with better functional outcomes.

This secondary analysis of the ENCHANTED2/MT randomized controlled trial evaluated 611 patients with successful reperfusion after endovascular thrombectomy for acute ischemic stroke. The analysis compared patients who achieved a systolic blood pressure within 24 hours after randomization in the 120-140 mm Hg group versus the 140-180 mm Hg group. The primary outcome was the modified Rankin Scale (mRS) score at 90 days.

For functional outcomes (mRS at 90 days), the 120-140 mm Hg group had better outcomes compared to the 140-180 mm Hg group (adjusted OR 1.54, 95% CI 1.10 to 2.17, P=0.013). The median mRS score was 2 (IQR 1-4) in the 120-140 mm Hg group versus 2 (IQR 1-5) in the 140-180 mm Hg group.

Neurological deterioration at 7 days was lower in the 120-140 mm Hg group (adjusted OR 0.68, 95% CI 0.47 to 0.98, P=0.037). Ninety-day mortality was also lower in the 120-140 mm Hg group (47 patients, 13.0%) compared to the 140-180 mm Hg group (53 patients, 21.4%) (adjusted OR 0.48, 95% CI 0.27 to 0.86, P=0.013).

Reported adverse events included early neurological decline, symptomatic intracranial hemorrhage, and any intracranial hemorrhage. Serious adverse events, discontinuations, and tolerability were not reported. Key limitations include the secondary analysis design and the specific population of patients with successful reperfusion after thrombectomy. Practice relevance is that an average SBP within 24 hours of 120-140 mm Hg was associated with a greater likelihood of functional independence compared with 140-180 mm Hg, but causation is not established.

A new look at a major stroke trial shows a simple number could change how doctors care for patients right after a life-saving procedure.

The First 24 Hours Are Critical

Imagine a loved one just survived a major stroke because doctors successfully removed a clot from their brain. They’re in the hospital, and now the focus shifts to protecting the brain from further damage. One of the biggest questions doctors face is: what should their blood pressure be?

For years, the answer has been unclear. Too high, and you risk swelling or bleeding in the brain. Too low, and you might not send enough blood to the injured area. Now, a new analysis of a major trial suggests a "sweet spot" for blood pressure that could make a real difference in recovery.

This isn't just about numbers on a monitor. It's about giving patients the best shot at getting back to their lives—walking, talking, and caring for themselves.

Acute ischemic stroke is one of the leading causes of death and disability worldwide. It happens when a blood clot blocks an artery in the brain. A procedure called endovascular thrombectomy (EVT) is a standard emergency treatment. It threads a catheter through the body to the brain to physically remove the clot.

The procedure itself is a huge advancement. But what happens after the clot is gone is just as important. The brain is in a fragile state. Managing blood pressure is a key part of post-surgery care, but the ideal target has been a subject of debate.

Current guidelines often suggest a broad range, leaving doctors to make judgment calls. This uncertainty can lead to inconsistent care. Patients and families are left hoping their medical team picks the right number. This new research aims to replace guesswork with clearer guidance.

The Old Way vs. The New Way

Traditionally, after successful clot removal, doctors aimed to keep systolic blood pressure (the top number in a reading) below 180 mmHg. The thinking was to prevent the brain from swelling or bleeding after the trauma of surgery.

But here’s the twist: a major trial called ENCHANTED2/MT previously found that aiming for a very low blood pressure (under 120 mmHg) after stroke surgery actually led to worse outcomes than a more standard approach. That study left many wondering where the ideal range truly lies.

This new analysis takes a closer look at that same trial data. Instead of comparing a very low target to a standard one, it asks a different question: Is there a "Goldilocks" zone in the middle? The researchers compared two groups: those whose blood pressure averaged between 120-140 mmHg and those whose averaged between 140-180 mmHg in the first 24 hours.

The old way was to avoid very high blood pressure. The new insight suggests that actively keeping it in a specific, moderate range—not too high, not too low—may be the key to better recovery.

How It Works: The "Goldilocks" Zone for Your Brain

Think of your brain like a delicate garden after a storm. The clot was the storm, and the surgery cleared the fallen tree. Now, the garden needs the right conditions to heal.

Blood pressure is like the water pressure in the garden's irrigation system.

  • Too high (over 180 mmHg): The water pressure is too strong. It can damage the delicate new sprouts and cause flooding (swelling or bleeding in the brain).
  • Too low (under 120 mmHg): The pressure is too weak. The water doesn't reach all the plants, especially the ones in the far corners that need it most. The injured parts of the brain don't get the oxygen-rich blood they need to repair themselves.
  • Just right (120-140 mmHg): The pressure is strong enough to deliver water to every part of the garden without causing damage. It provides steady, gentle support for healing.

This study suggests that finding this "just right" zone in the first 24 hours after surgery gives the brain the optimal environment to recover function.

A Closer Look at the Study

This research was a secondary analysis of the ENCHANTED2/MT trial, a large international study. The researchers looked at 611 patients who had successful clot removal for an acute ischemic stroke.

They divided these patients into two groups based on their average systolic blood pressure in the 24 hours after their procedure: 1. 120-140 mmHg group (363 patients) 2. 140-180 mmHg group (248 patients)

The main thing they measured was functional independence at 90 days, using a standard scale called the modified Rankin Scale (mRS). A score of 0-2 means the patient is independent, able to carry out their usual activities without significant help.

The results were clear and encouraging. Patients who kept their blood pressure in the 120-140 mmHg range had a significantly better chance of a good recovery.

Better Functional Outcomes

After adjusting for other factors, patients in the 120-140 mmHg group were 54% more likely to have a better functional outcome at 90 days compared to those in the 140-180 mmHg group. This means they were more likely to be independent and less disabled.

Lower Risk of Death

The difference in survival was also striking. At 90 days, 13% of patients in the lower blood pressure group had died, compared to 21.4% in the higher group. This suggests that managing blood pressure in this specific range could save lives.

Fewer Complications

Patients in the 120-140 mmHg group were also less likely to experience neurological deterioration in the first week after their stroke. Importantly, there was no increase in serious bleeding in the brain (intracranial hemorrhage) in this group, which is a key safety concern.

This doesn’t mean this treatment is available yet. These findings are from a secondary analysis and need to be confirmed in a dedicated clinical trial.

While this is not a new trial, it provides a powerful clue from a high-quality dataset. The findings help refine our understanding of post-stroke blood pressure management. It moves the conversation from "avoid high blood pressure" to "actively target a specific, moderate range." This could help doctors make more confident decisions in the critical hours after a stroke, potentially improving recovery for thousands of patients.

If you or a loved one is facing emergency stroke surgery, this research is reassuring. It shows that doctors are constantly refining their techniques to improve outcomes.

This is not yet a standard of care. The 120-140 mmHg target is a finding from a study, not a new rule. If you are in this situation, the best course of action is to trust your medical team. They are aware of the latest research and will use their clinical judgment to set the safest and most effective blood pressure goals for your specific condition.

You can always ask your doctor about their approach to blood pressure management after a stroke procedure. Being an informed patient or caregiver is always a positive step.

It's important to understand what this study can and cannot tell us. This was a secondary analysis, meaning the researchers went back to data from an existing trial to answer a new question. The original trial wasn't designed to test this specific blood pressure range.

The groups were not identical from the start, which the researchers tried to correct for with statistical analysis, but it's not the same as a randomized trial. Also, the study only included patients who had successful clot removal, so the results may not apply to all stroke patients.

So, what happens next? These findings are a strong signal, but they are not the final word. The next step would be a dedicated clinical trial that specifically randomizes patients to either the 120-140 mmHg target or the 140-180 mmHg target from the start.

This would provide the highest level of evidence needed to change clinical practice. While we don't have a timeline for such a trial or for any resulting changes to guidelines, this research adds a crucial piece to the puzzle. It brings us one step closer to a clearer, evidence-based plan for protecting the brain in its most vulnerable moments after a stroke.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: The optimal threshold or range for systolic blood pressure (SBP) control in patients with successful reperfusion after endovascular thrombectomy for acute ischemic stroke (AIS) remains undefined. This study investigated whether SBP within the first 24 hours after successful reperfusion correlates with functional outcomes in AIS. METHODS: In this secondary analysis of the ENCHANTED2/MT trial, patients were categorized into two groups (120-140 mm Hg and 140-180 mm Hg, respectively) based on achieved SBP within 24 hours after randomization. The primary outcome was the modified Rankin Scale (mRS) score at 90 days. Secondary outcomes included neurological deterioration at 7 days, major disability (mRS score of 3-5 at 90 days), hospitalization duration, and health-related quality of life assessed by the three-level EuroQoL 5-Dimension Self-Report Questionnaire (EQ-5D-3L) at 90 days. Safety outcomes included early neurological decline (END), 90-day mortality, symptomatic intracranial hemorrhage (sICH), and any intracranial hemorrhage (ICH). Treatment effects were expressed as ORs with 95% confidence intervals (CIs). RESULTS: A total of 611 patients (363 in the 120-140 mm Hg group and 248 in the 140-180 mm Hg group) were included. The mean (SD) age was 67 (12) years and 37.8% were female. After adjusting for confounders, the 120-140 mm Hg group was significantly associated with better functional outcomes (mRS: 2 (IQR 1-4) vs 2 (IQR 1-5); adjusted OR 1.54 (95% CI 1.10 to 2.17), P=0.013). Compared with the 140-180 mm Hg group, the 120-140 mm Hg group had lower rates of neurological deterioration at 7 days (adjusted OR 0.68 (95% CI 0.47 to 0.98), P=0.037) and 90-day mortality (47 (13.0%) vs 53 (21.4%); adjusted OR 0.48 (95% CI 0.27 to 0.86), P=0.013). There were no significant differences between groups in END, major disability at 90 days, hospitalization duration, EQ-5D-3L score, sICH, or ICH (all P>0.05). CONCLUSIONS: In patients with successful reperfusion after endovascular thrombectomy, an average SBP within 24 hours of 120-140 mm Hg was associated with a greater likelihood of functional independence compared with 140-180 mm Hg.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.